Gambacorti-Passerini C, Nicolini FE, Larson RA, Aroldi A, et al. Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. Am J Hematol 2022 May 23. doi: 10.1002/ajh.26618.
PMID: 35604243